medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 5

<< Back Next >>

Acta Pediatr Mex 2021; 42 (5)

Neonatal central venous catheter-associated thrombosis: a narrative review of the literature

Ruiz-Mejía C, Jaramillo-Jaramillo LI, Martínez-Sánchez LM, Villegas-Alzate JD, Álvarez-Hernández LF, Builes-Restrepo LN
Full text How to cite this article

Language: Spanish
References: 36
Page: 251-259
PDF size: 197.05 Kb.


Key words:

Central venous catheter, Neonatal intensive care, Thrombosis, Coagulation, Embolism, Catheter, Blood coagulation, Fibrinolytics, Neonates, Incidence, Prevalence.

ABSTRACT

Background: The application of a central venous catheter is an indispensable measure in neonatal intensive care units. Its use is associated with risk of thrombosis, which is the main cause of this complication in neonates.
Objective: To perform a narrative review of the current evidence and information available on this complication, and to identify possible sources of information for future research.
Methodology: Search in different databases with the descriptors: blood coagulation, thrombosis, embolism and catheters published in Spanish and English. Thirty-six articles were selected.
Results: Central venous catheter-associated thrombosis is a complication associated with the placement of a catheter in the vascular lumen. The worldwide incidence and prevalence of this complication in neonates has been little studied due, in part, to the difficulty in estimating the severity of the problem. In general, signs and symptoms depend on the location of the thrombus, despite the variability in the clinical picture and the fact that most thrombi associated with a central venous catheter are silent. Fibrinolytics (urokinase and alteplase) are indicated for treatment.
Conclusions: Complications arising from the application of central venous catheters, despite being a common technique, have not been fully studied and therefore their treatment in neonates is not standardized.


REFERENCES

  1. Van Ommen CH, Sol JJ. Developmental hemostasis and management of central venous catheter thrombosis in neonates. Semin Thromb Hemost 2016; 42 (7): 752-9. doi:10.1055/s-0036-1592299

  2. Haddad H, Lee KS, Higgins A, McMillian D, Price V, El-Naggar W. Routine surveillance ultrasound for the management of central venous catheters in neonates. J Pediatr 2014; 164 (1): 118-22. doi: 10.1016/j.jpeds.2013.08.048

  3. Park CK, Paes BA, Nagel K, Chan AK, Murthy P. Neonatal central venous catheter thrombosis: diagnosis, management and outcome. Blood Coagul Fibrinol 2014; 25: 97-106. doi: 10.1097/MBC.0b013e328364f9b0

  4. Sellitto M, Messina F. Central venous catheterization and thrombosis in newborns: update on diagnosis and management. J Matern Fetal Neonatal Med 2012; 25 (S4): 26-8. doi: 10.3109/14767058.2012.714974

  5. Palis J, Segel GB. Hematology of the Fetus and Newborn. In: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri M. eds. Williams Hematology, 9th ed. New York: McGraw-Hill, 2016.

  6. Vidal E, Sharathkumar A, Glover J, Faustino EVS. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis. J Thromb Haemost 2014; 12 (7): 1096-109. doi: 10.1111/jth.12773

  7. Bacciedoni V, Attie M, Donato H. Thrombosis in newborn infants. Arch Argent Pediatr 2016; 114 (2): 159-66.

  8. Giordano P, Saracco P, Grassi M, Luciani M, Banov L, Carraro F, et al. Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVCrelated thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Ann Hematol 2015; 94 (11): 1765-76. doi: 10.1007/s00277-015-2481-1

  9. Nifong TP, McDevitt TJ. The effect of catheter to vein ratio on blood flow rates in a simulated model of peripherally inserted central venous catheters. Chest 2011; 140 (1): 48-53. doi: 10.1378/chest.10-2637

  10. González FL, Lauria MJ. Determinación de valores de referencia para pruebas de coagulación en una población pediátrica. Acta Bioquím Clín Latinoam 2014; 48 (2): 237-41.

  11. Williams MD, Chalmers EA, Gibson BE. Haemostasis and thrombosis task force, British committee for standards in haematology. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol 2002; 119 (2): 295-309. doi: 10.1046/j.1365- 2141.2002.03674.x

  12. Saxonhouse M. Thrombosis in the Neonatal Intensive Care Unit. Clin Perinatol 2015; 42: 651-73. doi: 10.1016/j. clp.2015.04.010

  13. Hanmod SS, Jesudas R, Kulkarni R, Chitlur M. Neonatal hemostatic disorders: issues and challenges. Semin Thromb Hemost 2016; 42 (7): 741-51. doi: 10.1055/s- 0036-1593415

  14. Saxonhouse MA, Burchfield DJ. The evaluation and management of postnatal thrombosis. J Perinatol 2009; 29 (7): 467-78. doi: 10.1038/jp.2009.14

  15. Wu J, Mu D. Vascular catheter-related complications in newborns. J Paediatr Child Health 2012; 48 (2): E91-5. doi: 10.1111/j.1440-1754.2010.01934.x

  16. Manco M, Nuss R. Neonatal Thrombotic Disorders. Neo- Reviews 2000; 1 (10): e201-05.

  17. Jaffray J, Bauman M, Massicotte P. The impact of central venous catheters on pediatric venous thromboembolism. Front Pediatr 2017; 5 (5): 1-6. doi: 10.3389/ fped.2017.00005

  18. Gominet M, Compain F, Beloin C, Lebeaux D. Central venous catheters and biofilms: where do we stand in 2017? APMIS 2017; 125 (4): 365-75. doi: 10.1111/apm.12665

  19. Horikawa M, Quencer KB. Central venous interventions. Tech Vasc Interv Radiol 2017; 20 (1): 48-57. doi: 10.1053/j. tvir.2016.11.006

  20. Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, et al. Dressings and securement devices for central venous catheters (CVC). En: The Cochrane Collaboration, editor. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, 2013.

  21. Imigo GF, Elgueta CA, Castillo FE, Celedón LE, Fonfach ZC, Lavanderos FJ, et al. Accesos venosos centrales. Cuad Cir 2011; 25 (1): 52-8.

  22. Church JT, Jarboe MD. Vascular access in the pediatric population. Surg Clin North Am 2017; 97 (1): 113-28. doi: 10.1016/j.suc.2016.08.007

  23. Rosen BT, Wittnebel K. Chapter 115. Central Line Placement. In: McKean SC, Ross JJ, Dressler DD, Brotman DJ, Ginsberg JS. eds. Principles and practice of hospital medicine. New York: McGraw-Hill, 2012.

  24. Bhat S, Dahat A, Jain N, Nayak U, Patel V. Indications and complications of central venous catheterization in critically ill children in intensive care unit. Natl J Integr Res Med 2012; 2 (1): 85-8.

  25. Eisen LA. Mechanical complications of central venous catheters. J Intensive Care Med 2006; 21 (1): 40-6. doi: 10.1177/0885066605280884

  26. Wilson TJ, Brown DL, Meurer WJ, Stetler WR, Wilkinson DA, Fletcher JJ. Risk factors associated with peripherally inserted central venous catheter-related large vein thrombosis in neurological intensive care patients. Intensive Care Med 2012; 38 (2): 272-8. doi: 10.1007/ s00134-011-2418-7

  27. Smitherman AB, Alexander T, Connelly M, Snavely AC, Weston BW, Liles EA, et al. The incidence of catheter-associated venous thrombosis in noncritically ill children. Hosp Pediatr 2015; 5 (2): 59-66. doi: 10.1542/hpeds.2014-0041

  28. Fallouh N, McGuirk HM, Flanders SA, Chopra V. Peripherally inserted central catheter-associated deep vein thrombosis: A narrative review. Am J Med 2015; 128 (7): 722-38. doi: 10.1016/j.amjmed.2015.01.027

  29. Saracco P, Bagna R, Gentilomo C, Magarotto M, Viano A, Magnetti F, et al. Clinical data of neonatal systemic thrombosis. J Pediatr 2016; 171: 60-6.e1. doi: 10.1016/j. jpeds.2015.12.035

  30. Cortejoso L, Manrique-Rodríguez S, Fernández-Llamazares CM, Sanjurjo-Sáez M. Treatment and prophylaxis of catheter- related thromboembolic events in children. J Pharm Pharm Sci 2012; 15 (5): 632-41.

  31. Sol JJ, Knoester H, de Neef M, Smets AMJB, Betlem A, van Ommen CH. Chronic complications after femoral central venous catheter-related thrombosis in critically Ill children. J Pediatr Hematol Oncol 2015; 37 (6): 462-7. doi: 10.1097/ MPH.0000000000000370

  32. Debourdeau P, Farge D, Beckers M, Baglin C, Bauersachs RM, Brenner B, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer: International guidelines on catheter-related thrombosis. J Thromb Haemost 2013; 11 (1): 71-80. doi: 10.1111/jth.12071

  33. De Lorenzo-Pinto A, Sánchez-Galindo AC, Manrique- Rodríguez S, Fernández-Llamazares CM, Fernández-Lafever SN, San-Prudencio MG, et al. Prevention and treatment of intraluminal catheter thrombosis in children hospitalized in a paediatric intensive care unit. J Paediatr Child Health 2014; 50 (1): 40-46. doi: 10.1111/jpc.12404

  34. Bracho-Blanchet E, Cortés-Sauza J, Dávila-Pérez R, Lezama-Del Valle P, Villalobos-Alfaro C, Nieto-Zermeño J. Usefulness of intravenous heparin to prevent thrombosis of central venous catheter in children. Cir Cir 2010; 78 (5): 423-9.

  35. Gasior AC, Marty Knott E, St Peter SD. Management of peripherally inserted central catheter associated deep vein thrombosis in children. Pediatr Surg Int 2013; 29 (5): 445-9. doi: 10.1007/s00383-013-3259-y

  36. Davies GA, Lazo-Langner A, Gandara E, Rodger M, Tagalakis V, Louzada M, et al. A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2). Thromb Res 2017. pii: S0049-3848 (17): 30257-8. doi: 10.1016/j. thromres.2017.04.003.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2021;42